首页> 外文期刊>Obesity >Treatment with a SOD mimetic reduces visceral adiposity, adipocyte death, and adipose tissue inflammation in high fat-fed mice
【24h】

Treatment with a SOD mimetic reduces visceral adiposity, adipocyte death, and adipose tissue inflammation in high fat-fed mice

机译:用SOD模拟物治疗可减少高脂喂养小鼠的内脏脂肪沉积,脂肪细胞死亡和脂肪组织炎症

获取原文
获取原文并翻译 | 示例
           

摘要

Objective Obesity is associated with enhanced reactive oxygen species (ROS) accumulation in adipose tissue. However, a causal role for ROS in adipose tissue expansion after high fat feeding is not established. The aim of this study is to investigate the effect of the cell permeable superoxide dismutase mimetic and peroxynitrite scavenger Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP) on adipose tissue expansion and remodeling in response to high fat diet (HFD) in mice. Design and Methods Male C57BL/6j mice were fed normal chow or high fat diet (HFD) and treated with saline or MnTBAP for 5 weeks. The effects of MnTBAP on body weights, whole body energy expenditure, adipose tissue morphology, and gene expression were determined. Results MnTBAP attenuated weight gain and adiposity through a reduction in adipocyte hypertrophy, adipogenesis, and fatty acid uptake in epididymal (eWAT) but not in inguinal (iWAT) white adipose tissue. Furthermore, MnTBAP reduced adipocyte death and inflammation in eWAT and diminished circulating levels of free fatty acids and leptin. Despite these improvements, the development of systemic insulin resistance and diabetes after HFD was not prevented with MnTBAP treatment. Conclusions Taken together, these data suggest a causal role for ROS in the development of diet-induced visceral adiposity but not in the development of insulin resistance and type 2 diabetes.
机译:目的肥胖与脂肪组织中活性氧(ROS)积累的增加有关。然而,高脂肪喂养后ROS在脂肪组织扩张中的因果作用尚未建立。本研究的目的是研究细胞可渗透的超氧化物歧化酶模拟物和过氧亚硝酸盐清除剂Mn(III)四(4-苯甲酸)卟啉氯化物(MnTBAP)对高脂肪饮食(HFD)响应的脂肪组织扩张和重塑的影响)。设计与方法给雄性C57BL / 6j小鼠喂食普通食物或高脂饮食(HFD),并用盐水或MnTBAP处理5周。确定了MnTBAP对体重,全身能量消耗,脂肪组织形态和基因表达的影响。结果MnTBAP通过减少附睾(eWAT)腹股沟(iWAT)白色脂肪组织中的脂肪细胞肥大,脂肪形成和脂肪酸摄取而减少体重增加和肥胖。此外,MnTBAP减少了eWAT中的脂肪细胞死亡和炎症,并减少了游离脂肪酸和瘦素的循环水平。尽管有这些改进,但MnTBAP治疗并不能阻止HFD后全身胰岛素抵抗和糖尿病的发展。结论综上所述,这些数据表明ROS在饮食诱导的内脏肥胖的发生中起因果作用,但在胰岛素抵抗和2型糖尿病的发生中不起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号